Selective Bibliography of Dr. Terry Van Dyke
Head, Cancer Pathways and Mechanisms Program Director
Mouse Cancer Genetics Program

"Deciphering the Complexities of Cancer Pathways and Mechanisms in Vivo"
Wednesday, April 30, 2008

4. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM.
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
GENOME BIOLOGY 8(5): R76, May 2007

5. Van Dyke T.
p53 and tumor suppression
NEW ENGLAND JOURNAL OF MEDICINE 356(1): 79-81, Jan 2007

6. McLear JA, Garcia-Fresco G, Bhat MA, Van Dyke TA.
In vivo inactivation of pRb, p107 and p130 in murine neuroprogenitor cells leads to major CNS developmental defects and high seizure rates
MOLECULAR AND CELLULAR NEUROSCIENCE 33(3): 260-73, Nov 2006

7. Bullitt E, Wolthusen PA, Brubaker L, Lin W, Zeng D, Van Dyke T.
Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice
AMERICAN JOURNAL OF NEURORADIOLOGY 27(3): 612-9 Mar 2006

8. Gutmann DH, Maher EA, Van Dyke T.
Mouse Models of Human Cancers Consortium Workshop on Nervous System Tumors
CANCER RESEARCH 66(1): 10-13, Jan 2006

9. Hill R, Song Y, Cardiff RD, Van Dyke T.
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis
CELL 123(6): 1001-11, Dec 2005.

10. Hill R, Song Y, Cardiff RD, Van Dyke T.
Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model.
CANCER RESEARCH 65(22): 10243-54, Nov 2005

Created 4/7/08